Rocket Pharmaceuticals, Inc. (RCKT) insider trading.
In Q3 2026, insiders at Rocket Pharmaceuticals, Inc. reported 15 non-derivative transactions on 16 Forms 3, 4 and 5: 0 open-market purchases and 7 sales worth $432K.
- Transactions
- 15
- Purchases (P)
- 0
- Sales (S)
- 7
- Net shares, P minus S
- -125,977
- Insiders
- 10
- Last filed
- 2026-09-15
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Wilson Martin | Officer · General Counsel | 3 | 0 | 3 |
| Shah Gaurav | Officer · CEO | 2 | 0 | 2 |
| Stevens Christopher James | Officer · Chief Operating Officer | 2 | 0 | 1 |
| Southwell David P | Director | 2 | 0 | 0 |
| Chaudhuri Sarbani | Officer · See Remarks | 1 | 0 | 1 |
| Boess Carsten | Director | 1 | 0 | 0 |
| Malik Fady Ibraham | Director | 1 | 0 | 0 |
| Dolsten Mikael | Director | 1 | 0 | 0 |
| Fong Peter | Director | 1 | 0 | 0 |
| Wong Roderick | Director, TenPercentOwner | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-11 | Wilson Martin | S (D) | 75,364 | $3.4 | 598,489 | Form 4 |
| 2026-08-18 | Shah Gaurav | S (D) | 2,293 | $3.38 | 1,056,594 | Form 4 |
| 2026-08-18 | Wilson Martin | S (D) | 631 | $3.38 | 673,853 | Form 4 |
| 2026-08-13 | Wilson Martin | S (D) | 3,493 | $3.38 | 674,484 | Form 4 |
| 2026-08-13 | Shah Gaurav | S (D) | 2,837 | $3.38 | 1,058,887 | Form 4 |
| 2026-08-11 | Chaudhuri Sarbani | S (D) | 4,701 | $3.5 | 262,809 | Form 4 |
| 2026-08-11 | Stevens Christopher James | S (D) | 36,658 | $3.5 | 505,784 | Form 4 |
| 2026-08-03 | Southwell David P | J (A) | 150,000 | $0 | 204,522 | Form 4 |
| 2026-08-03 | Stevens Christopher James | A (A) | 73,313 | $0 | 542,442 | Form 4 |
| 2026-06-18 | Boess Carsten | A (A) | 22,862 | $0 | 52,862 | Form 4 |
| 2026-06-18 | Southwell David P | A (A) | 22,862 | $0 | 54,522 | Form 4 |
| 2026-06-18 | Malik Fady Ibraham | A (A) | 22,862 | $0 | 52,862 | Form 4 |
| 2026-06-18 | Dolsten Mikael | A (A) | 22,862 | $0 | 67,082 | Form 4 |
| 2026-06-18 | Fong Peter | A (A) | 22,862 | $0 | 76,195 | Form 4 |
| 2026-06-18 | Wong Roderick | A (A) | 27,832 | $0 | 75,499 | Form 4 |
Transaction codes in this quarter
Get RCKT insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1281895&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · RCKT company page · Rocket Pharmaceuticals, Inc. on SEC.gov
Questions
Are insiders buying or selling Rocket Pharmaceuticals, Inc. (RCKT)?
In Q3 2026, insiders at Rocket Pharmaceuticals, Inc. reported 15 non-derivative transactions on 16 Forms 3, 4 and 5: 0 open-market purchases and 7 sales worth $432K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Rocket Pharmaceuticals, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/rckt.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.